Solbinsiran for severe high triglycerides
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called solbinsiran (LY3561774) for people with very high triglyceride levels. It aims to see if it can lower these fats in your blood and reduce the risk of pancreatitis or heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had very high triglyceride levels (≥500 mg/dL) in the past and again at two separate tests during screening.
- Your body mass index (BMI) must be between 18.5 and 45.0.
- You cannot have had a major heart attack, stroke, or similar event in the last 3 months.
- You cannot have a known genetic condition called Familial Chylomicronemia Syndrome.
- You cannot have a history of heavy alcohol abuse in the last 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called DR10624 compared to a placebo in people with severely high triglycerides (fats in the blood). It aims to see if the drug can safely lower these fats and reduce the risk of related health problems like pancreatitis.
This study tests an investigational drug called plozasiran for people with severely high triglycerides that have already caused pancreatitis (inflammation of the pancreas). The goal is to see if the drug can lower triglycerides and help prevent future attacks.
This trial tests a new medicine called ION775 to help lower very high triglyceride levels in the blood. Triglycerides are a type of fat, and having too much can increase heart disease risk. The study will check if ION775 is safe and actually works when added to your regular cholesterol medications.
This trial tests an experimental drug called CS-121 for people with very high triglyceride levels that don't improve with standard treatments. It uses a new gene-editing approach to lower triglycerides and aims to reduce the risk of pancreatitis and other complications.
This trial tests a new injectable drug called DR10624 for people with very high triglyceride levels. It aims to lower triglycerides and reduce the risk of pancreatitis (inflammation of the pancreas).
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
Hear when a new Severe Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.